1. Home
  2. FONR vs ADVM Comparison

FONR vs ADVM Comparison

Compare FONR & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FONR
  • ADVM
  • Stock Information
  • Founded
  • FONR 1978
  • ADVM 2006
  • Country
  • FONR United States
  • ADVM United States
  • Employees
  • FONR N/A
  • ADVM N/A
  • Industry
  • FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FONR Health Care
  • ADVM Health Care
  • Exchange
  • FONR Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • FONR 100.2M
  • ADVM 119.6M
  • IPO Year
  • FONR 1987
  • ADVM 2014
  • Fundamental
  • Price
  • FONR $14.75
  • ADVM $3.94
  • Analyst Decision
  • FONR
  • ADVM Strong Buy
  • Analyst Count
  • FONR 0
  • ADVM 6
  • Target Price
  • FONR N/A
  • ADVM $27.83
  • AVG Volume (30 Days)
  • FONR 17.9K
  • ADVM 149.4K
  • Earning Date
  • FONR 02-18-2025
  • ADVM 03-17-2025
  • Dividend Yield
  • FONR N/A
  • ADVM N/A
  • EPS Growth
  • FONR N/A
  • ADVM N/A
  • EPS
  • FONR 1.17
  • ADVM N/A
  • Revenue
  • FONR $101,570,089.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • FONR N/A
  • ADVM N/A
  • Revenue Next Year
  • FONR N/A
  • ADVM $1,342.84
  • P/E Ratio
  • FONR $12.56
  • ADVM N/A
  • Revenue Growth
  • FONR N/A
  • ADVM N/A
  • 52 Week Low
  • FONR $14.05
  • ADVM $3.85
  • 52 Week High
  • FONR $23.41
  • ADVM $22.30
  • Technical
  • Relative Strength Index (RSI)
  • FONR 37.71
  • ADVM 38.74
  • Support Level
  • FONR $14.63
  • ADVM $3.85
  • Resistance Level
  • FONR $17.62
  • ADVM $4.63
  • Average True Range (ATR)
  • FONR 0.53
  • ADVM 0.30
  • MACD
  • FONR -0.16
  • ADVM -0.01
  • Stochastic Oscillator
  • FONR 4.03
  • ADVM 8.76

About FONR Fonar Corporation

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.

Share on Social Networks: